BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15538755)

  • 21. Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
    Emmerich F; Theurich S; Hummel M; Haeffker A; Vry MS; Döhner K; Bommert K; Stein H; Dörken B
    J Pathol; 2003 Nov; 201(3):413-20. PubMed ID: 14595753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
    Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
    Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Global gene expression analysis and novel signalling pathways in Hodgkin lymphoma].
    Bräuninger A; Renné C; Willenbrock K; Martin-Subero JI; Hinsch N; Tiacci E; Siebert R; Küppers R; Hansmann ML
    Verh Dtsch Ges Pathol; 2006; 90():136-41. PubMed ID: 17867590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular origin and clonality of classic Hodgkin's lymphoma: immunophenotypic and molecular studies.
    Stein H; Hummel M
    Semin Hematol; 1999 Jul; 36(3):233-41. PubMed ID: 10462323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large B-cell lymphoma with Hodgkin's features.
    García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
    Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.
    Torlakovic E; Tierens A; Dang HD; Delabie J
    Am J Pathol; 2001 Nov; 159(5):1807-14. PubMed ID: 11696441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
    Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
    J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma.
    Khnykin D; Troen G; Berner JM; Delabie J
    J Pathol; 2006 Feb; 208(3):431-8. PubMed ID: 16353171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
    Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
    J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity.
    Mathas S
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):787-804. PubMed ID: 17908620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of cholesteryl ester transfer protein (CETP) in germinal centre B cells and their neoplastic counterparts.
    Ito K; Ishikawa F; Kanno T; Ishikawa Y; Akasaka Y; Akishima Y; Ishii T; Terayama Y; Sugimoto M; Watanabe T; Mori S
    Histopathology; 2004 Jul; 45(1):73-81. PubMed ID: 15228446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1.
    Tzankov A; Zimpfer A; Lugli A; Krugmann J; Went P; Schraml P; Maurer R; Ascani S; Pileri S; Geley S; Dirnhofer S
    J Pathol; 2003 Feb; 199(2):201-7. PubMed ID: 12533833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
    Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
    Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Hodgkin and Reed/Sternberg cell.
    Küppers R; Hansmann ML
    Int J Biochem Cell Biol; 2005 Mar; 37(3):511-7. PubMed ID: 15618006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.
    Renné C; Martin-Subero JI; Eickernjäger M; Hansmann ML; Küppers R; Siebert R; Bräuninger A
    Am J Pathol; 2006 Aug; 169(2):655-64. PubMed ID: 16877363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.